NO20081503L - T-celle adhesjonsmolekyl, og antistoff dertil - Google Patents

T-celle adhesjonsmolekyl, og antistoff dertil

Info

Publication number
NO20081503L
NO20081503L NO20081503A NO20081503A NO20081503L NO 20081503 L NO20081503 L NO 20081503L NO 20081503 A NO20081503 A NO 20081503A NO 20081503 A NO20081503 A NO 20081503A NO 20081503 L NO20081503 L NO 20081503L
Authority
NO
Norway
Prior art keywords
seq
adhesion molecule
cell adhesion
antibody
present
Prior art date
Application number
NO20081503A
Other languages
English (en)
Norwegian (no)
Inventor
Hideaki Ogasawara
Keiko Mizuno
Yoshihisa Arita
Miyuki Nishimura
Toshio Imai
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of NO20081503L publication Critical patent/NO20081503L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/7051—T-cell receptor (TcR)-CD3 complex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20081503A 2005-09-29 2008-03-28 T-celle adhesjonsmolekyl, og antistoff dertil NO20081503L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005285194 2005-09-29
PCT/JP2006/319576 WO2007037430A1 (ja) 2005-09-29 2006-09-29 Ｔ細胞接着分子およびそれに対する抗体

Publications (1)

Publication Number Publication Date
NO20081503L true NO20081503L (no) 2008-06-30

Family

ID=37899850

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081503A NO20081503L (no) 2005-09-29 2008-03-28 T-celle adhesjonsmolekyl, og antistoff dertil

Country Status (17)

Country Link
US (1) US20090181025A1 (es)
EP (1) EP1939288B1 (es)
JP (1) JP5106111B2 (es)
KR (1) KR101026016B1 (es)
CN (1) CN101316930B (es)
AU (1) AU2006295717B2 (es)
BR (1) BRPI0616438A2 (es)
CA (1) CA2624135C (es)
DK (1) DK1939288T3 (es)
ES (1) ES2400520T3 (es)
HK (1) HK1119448A1 (es)
IL (2) IL190488A (es)
MY (1) MY150639A (es)
NO (1) NO20081503L (es)
NZ (1) NZ567043A (es)
RU (1) RU2396275C2 (es)
WO (1) WO2007037430A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010123119A1 (ja) * 2009-04-23 2010-10-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 炎症性腸疾患治療剤およびそのスクリーニング方法
AR104833A1 (es) * 2015-07-01 2017-08-16 Syngenta Participations Ag Composiciones y métodos para controlar plagas de plantas
JP7280586B2 (ja) * 2018-10-15 2023-05-24 学校法人東京理科大学 樹状細胞の成熟抑制剤及び成熟抑制方法、並びに医薬組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH0373280A (ja) 1989-03-20 1991-03-28 Kunii Nakada タガネ及びその装着用ホルダー
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
WO1994025585A1 (en) 1993-04-26 1994-11-10 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
EP0814159B1 (en) 1990-08-29 2005-07-27 GenPharm International, Inc. Transgenic mice capable of producing heterologous antibodies
EP0652950B1 (en) 1992-07-24 2007-12-19 Amgen Fremont Inc. Generation of xenogeneic antibodies
EP1190051A2 (en) * 1999-06-17 2002-03-27 Incyte Genomics, Inc. Human transport proteins
ES2317847T3 (es) * 1999-08-31 2009-05-01 Genentech, Inc. Composiciones y procedimientos para el tratamiento de enfermedades de tipo inmunologico.
JP2004524001A (ja) * 2000-01-25 2004-08-12 ハイセック，インコーポレーテッド 白血球免疫グロブリン受容体（ｌｉｒ様）ポリペプチドおよびポリヌクレオチドに関する方法と材料
WO2001055335A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
US20030187201A1 (en) * 2000-09-15 2003-10-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
JPWO2007037430A1 (ja) 2009-04-16
IL190488A0 (en) 2008-11-03
RU2008116833A (ru) 2009-11-10
IL211031A0 (en) 2011-04-28
HK1119448A1 (en) 2009-03-06
RU2396275C2 (ru) 2010-08-10
US20090181025A1 (en) 2009-07-16
AU2006295717A1 (en) 2007-04-05
BRPI0616438A2 (pt) 2012-12-25
CA2624135A1 (en) 2007-04-05
EP1939288A4 (en) 2010-05-26
IL190488A (en) 2016-09-29
NZ567043A (en) 2012-08-31
EP1939288B1 (en) 2012-12-19
MY150639A (en) 2014-02-14
CN101316930B (zh) 2013-06-19
JP5106111B2 (ja) 2012-12-26
CA2624135C (en) 2015-06-30
KR101026016B1 (ko) 2011-03-30
KR20080068039A (ko) 2008-07-22
CN101316930A (zh) 2008-12-03
DK1939288T3 (da) 2013-03-11
WO2007037430A1 (ja) 2007-04-05
EP1939288A1 (en) 2008-07-02
AU2006295717B2 (en) 2012-01-19
ES2400520T3 (es) 2013-04-10

Similar Documents

Publication Publication Date Title
HRP20090245T1 (en) Pyy agonists and uses thereof
RS54133B1 (en) ANTI-IL-6 ANTIBODIES, PREPARATIONS, PREPARATION AND USE PROCEDURES
RS54405B1 (en) HUMANIZED ANTI-FACTOR ANTIBODIES AND THEIR APPLICATIONS
NO20063026L (no) Antistoffer
BRPI0516176A (pt) polipeptìdeo, dna, microorganismo, e, processo para produzir l-arginina, l-ornitina ou l-citrulina
EA201000327A1 (ru) Белок
BR112013010487A2 (pt) novos substratos de coelenterazina e métodos de uso
DE602006018856D1 (de) Neue nutrazeutika-zusammensetzungen
EA201170879A1 (ru) Полипептиды с ксиланазной активностью
AR053259A1 (es) Trigo con nuevo almidon y metodo para producirlo
PE20120170A1 (es) Variantes de union a anti-albumina de suero mejoradas
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular
AR120891A1 (es) Proteína rsv f mutante y su uso
RS54451B1 (en) TOLL-LIKE RECEPTOR ANTAGONISTS 3
EP4269562A3 (en) Antigen binding molecules and methods of use thereof
ATE495247T1 (de) Chromoprotein und fluoroproteine
NO20081503L (no) T-celle adhesjonsmolekyl, og antistoff dertil
TR200400639T4 (tr) Donmaya-karşı proteinler, bunların üretimleri ve kullanımları
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
NZ591133A (en) Novel melanoma antigen peptide and uses thereof
WO2008146259A3 (en) Malt1 specific cleavage in assay and screening method
CY1111630T1 (el) Παραγωγα κυτοκινων

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application